IGF1R and hepatocellular carcinoma: The present data confirmed that acting on IGF-IR should have effect on the biological functions of HCC cells in vitro through the IGF-II/IGF-IR pathway, suggesting that the IGF-IR pathway should be a novel therapeutic target for HCC.